Cargando…

Managing complex perianal disease after anti-TNF failure: Where to go next?

Crohn's disease is a chronic inflammatory bowel disease that affects various intestinal segments and can involve the perianal region. Although anti-tumor necrosis factor (TNF) agents have revolutionized the management of Crohn's disease and improved the prognosis for patients with perianal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yzet, Clare, Brazier, Franck, Sabbagh, Charles, Fumery, Mathurin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Medical Management of IBD Edited by Joana Torres and Ryan Ungaro
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784625/ https://www.ncbi.nlm.nih.gov/pubmed/35106477 http://dx.doi.org/10.1016/j.crphar.2022.100081

Ejemplares similares

Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
por: Alsoud, Dahham, et al.
Publicado: (2022)

When disease extent is not always a key parameter: Management of refractory ulcerative proctitis
por: Michalopoulos, Georgios, et al.
Publicado: (2021)

Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom?
por: Juillerat, Pascal, et al.
Publicado: (2022)

Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy?
por: Atreya, Raja, et al.
Publicado: (2022)

Unmet needs in inflammatory bowel disease
por: Revés, Joana, et al.
Publicado: (2021)

Medical management of chronic pouch inflammation
por: Kayal, Maia, et al.
Publicado: (2022)

User's guide to JAK inhibitors in inflammatory bowel disease
por: Spiewak, Ted A., et al.
Publicado: (2022)

Editorial/introduction to special issue
por: Torres, Joana, et al.
Publicado: (2022)

Going Viral: Management of IBD in the Era of the COVID-19 Pandemic
por: Gutin, Liat S., et al.
Publicado: (2020)

Where Are We and Where to Next?—The Future of Perianal Crohn’s Disease Management
por: Anandabaskaran, Sulak, et al.
Publicado: (2023)

IBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
por: Le, Peter N., et al.
Publicado: (2015)

A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease
por: Piester, Travis, et al.
Publicado: (2018)

Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease
por: Han, Lichy, et al.
Publicado: (2018)

The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease
por: Anderson, Alyce, et al.
Publicado: (2018)

Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population‐based cohort study
por: Eriksson, Carl, et al.
Publicado: (2018)

Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis
por: Mahadevan, Uma, et al.
Publicado: (2018)

Infliximab for Crohn’s Disease: More Than 13 Years of Real-world Experience
por: Lichtenstein, Gary R, et al.
Publicado: (2018)

What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?
por: Card, Timothy, et al.
Publicado: (2018)

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases
por: Ghosh, Subrata, et al.
Publicado: (2017)

Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient–Physician Visits
por: Rubin, David T., et al.
Publicado: (2017)

Risk of dementia in patients with inflammatory bowel disease: a Danish population‐based study
por: Rønnow Sand, Jakob, et al.
Publicado: (2022)

Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients
por: Lam, Angela Y., et al.
Publicado: (2020)

Opportunistic Knocks: A Gardener with Ulcerative Colitis and New Pulmonary Nodules
por: Canakis, Andrew, et al.
Publicado: (2023)

Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease
por: Darlington, Kimberly, et al.
Publicado: (2023)

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study
por: Chanchlani, Neil, et al.
Publicado: (2022)

Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel disease
por: Vollebregt, P. F., et al.
Publicado: (2018)

Single-use duodenoscopes: where are we and where are we going?
por: Peter, Shajan, et al.
Publicado: (2021)

Where is genomics going next?
por: Cheifet, Barbara
Publicado: (2019)

The living universe: where are we? who are we? where are we going?
por: Elgin, Duane, et al.
Publicado: (2009)

Where Do Omics and Markers Go Next?
por: Sharp, Frank R.
Publicado: (2010)

Traditional Medicines in the World: Where to Go Next?
por: Pan, Si-Yuan, et al.
Publicado: (2014)

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
por: Kennedy, N A, et al.
Publicado: (2014)

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy
por: Colombel, J.‐F., et al.
Publicado: (2016)

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022)

The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases—an international Delphi consensus survey
por: Madsen, Gorm Roager, et al.
Publicado: (2022)

Minor impact on fertility in men with inflammatory bowel disease: A National Cohort Study from Sweden
por: Druvefors, Emma, et al.
Publicado: (2022)

Population pharmacokinetics of subcutaneous infliximab CT‐P13 in Crohn’s disease and ulcerative colitis
por: Hanzel, Jurij, et al.
Publicado: (2021)

Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population‐based study
por: Jayasooriya, Nishani, et al.
Publicado: (2022)

Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis
por: Lyons, Mathew, et al.
Publicado: (2022)

Endoscopic submucosal resection with adaptative traction device: a new strategy to facilitate resection in patient with inflammatory bowel disease
por: Masgnaux, Louis-Jean, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jb69ofhu7oqhpbnckhefp18pqp